Your browser doesn't support javascript.
loading
Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer.
Pradat, Yoann; Viot, Julien; Yurchenko, Andrey A; Gunbin, Konstantin; Cerbone, Luigi; Deloger, Marc; Grisay, Guillaume; Verlingue, Loic; Scott, Véronique; Padioleau, Ismael; Panunzi, Leonardo; Michiels, Stefan; Hollebecque, Antoine; Jules-Clément, Gérôme; Mezquita, Laura; Lainé, Antoine; Loriot, Yohann; Besse, Benjamin; Friboulet, Luc; André, Fabrice; Cournède, Paul-Henry; Gautheret, Daniel; Nikolaev, Sergey I.
Afiliação
  • Pradat Y; Université Paris-Saclay, CentraleSupélec, MICS lab, Gif-Sur-Yvette, France.
  • Viot J; Gustave Roussy, Department of Medical Oncology, Villejuif, France.
  • Yurchenko AA; Centre Hospitalier Régional Universitaire de Besançon, Department of Medical Oncology, Besançon, France.
  • Gunbin K; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.
  • Cerbone L; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.
  • Deloger M; Gustave Roussy, Department of Medical Oncology, Villejuif, France.
  • Grisay G; Gustave Roussy, Université Paris-Saclay, Bioinformatics Core Facility, Inserm US23, CNRS UMS 3655, Villejuif, France.
  • Verlingue L; Gustave Roussy, Department of Medical Oncology, Villejuif, France.
  • Scott V; Gustave Roussy, Department of Medical Oncology, Villejuif, France.
  • Padioleau I; Gustave Roussy, Early Drug Development Department (DITEP), Villejuif, France.
  • Panunzi L; Gustave Roussy, Department of Medical Oncology, Villejuif, France.
  • Michiels S; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.
  • Hollebecque A; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.
  • Jules-Clément G; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.
  • Mezquita L; Gustave Roussy, Department of Biostatistics and Epidemiology, Villejuif, France.
  • Lainé A; Gustave Roussy, Department of Medical Oncology, Villejuif, France.
  • Loriot Y; Gustave Roussy, Early Drug Development Department (DITEP), Villejuif, France.
  • Besse B; Gustave Roussy, Université Paris-Saclay, Bioinformatics Core Facility, Inserm US23, CNRS UMS 3655, Villejuif, France.
  • Friboulet L; Gustave Roussy, Department of Medical Oncology, Villejuif, France.
  • André F; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.
  • Cournède PH; Gustave Roussy, Department of Medical Oncology, Villejuif, France.
  • Gautheret D; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.
  • Nikolaev SI; Gustave Roussy, Early Drug Development Department (DITEP), Villejuif, France.
Cancer Discov ; 13(5): 1116-1143, 2023 05 04.
Article em En | MEDLINE | ID: mdl-36862804
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Segunda Neoplasia Primária Limite: Humans / Male Idioma: En Revista: Cancer Discov Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Segunda Neoplasia Primária Limite: Humans / Male Idioma: En Revista: Cancer Discov Ano de publicação: 2023 Tipo de documento: Article